These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 19297635
1. Risk/benefit ratio of androgen deprivation treatment for sex offenders. Berlin FS. J Am Acad Psychiatry Law; 2009; 37(1):59-62. PubMed ID: 19297635 [Abstract] [Full Text] [Related]
2. Potential side effects of androgen deprivation treatment in sex offenders. Giltay EJ, Gooren LJ. J Am Acad Psychiatry Law; 2009; 37(1):53-8. PubMed ID: 19297634 [Abstract] [Full Text] [Related]
3. Drug treatment of paraphilic and nonparaphilic sexual disorders. Guay DR. Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704 [Abstract] [Full Text] [Related]
4. [Treatment of sex offenders with leuprorelin]. Nøttestad JA, Bjarnar E, Lundmo PI, Sandvik M. Tidsskr Nor Laegeforen; 2006 Feb 23; 126(5):633-4. PubMed ID: 16505878 [No Abstract] [Full Text] [Related]
5. Metabolic and cardiovascular effects of androgen deprivation therapy. Hakimian P, Blute M, Kashanian J, Chan S, Silver D, Shabsigh R. BJU Int; 2008 Dec 23; 102(11):1509-14. PubMed ID: 18727614 [Abstract] [Full Text] [Related]
6. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Melella JT, Travin S, Cullen K. Bull Am Acad Psychiatry Law; 1989 Dec 23; 17(3):223-32. PubMed ID: 2529005 [Abstract] [Full Text] [Related]
7. Pathologic effects of testosterone deprivation. Sprenkle PC, Fisch H. Curr Opin Urol; 2007 Nov 23; 17(6):424-30. PubMed ID: 17921778 [Abstract] [Full Text] [Related]
8. Clinical review: Ethical and medical considerations of androgen deprivation treatment of sex offenders. Gooren LJ. J Clin Endocrinol Metab; 2011 Dec 23; 96(12):3628-37. PubMed ID: 21956411 [Abstract] [Full Text] [Related]
9. [Diagnosis and treatment of osteoporosis in male hypogonadism]. Tsukamoto T, Itoh N. Clin Calcium; 2006 Mar 23; 16(3):481-5. PubMed ID: 16508132 [Abstract] [Full Text] [Related]
10. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports. Grasswick LJ, Bradford JM. J Forensic Sci; 2003 Jul 23; 48(4):849-55. PubMed ID: 12877306 [Abstract] [Full Text] [Related]
11. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. Bhoopalam N, Campbell SC, Moritz T, Broderick WR, Iyer P, Arcenas AG, Van Veldhuizen PJ, Friedman N, Reda D, Warren S, Garewal H. J Urol; 2009 Nov 23; 182(5):2257-64. PubMed ID: 19758618 [Abstract] [Full Text] [Related]
12. Policing "perversions": Depo-Provera and John Money's new sexual order. Tsang DC. J Homosex; 1995 Nov 23; 28(3-4):397-426. PubMed ID: 7560938 [Abstract] [Full Text] [Related]
16. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. Wadhwa VK, Weston R, Mistry R, Parr NJ. BJU Int; 2009 Sep 23; 104(6):800-5. PubMed ID: 19338564 [Abstract] [Full Text] [Related]
19. [Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin]. Briken P, Welzel K, Habermann N, Hill A, Berner W. Psychiatr Prax; 2009 Jul 23; 36(5):232-7. PubMed ID: 19437383 [Abstract] [Full Text] [Related]